Transcripts

Belite Bio (BLTE) earnings call transcripts

Earnings call transcripts for Belite Bio, Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed the call around regulatory execution, with FDA review prioritized over Europe and near-term geographic atrophy updates. Dragon 2 is not expected to contribute to the U.S.

    Aug 13, 2026Confident0.78